ABCL
Price
$4.74
Change
+$0.09 (+1.94%)
Updated
Sep 26 closing price
Capitalization
1.42B
45 days until earnings call
GLPG
Price
$33.78
Change
+$1.12 (+3.43%)
Updated
Sep 26 closing price
Capitalization
2.16B
39 days until earnings call
Interact to see
Advertisement

ABCL vs GLPG

Header iconABCL vs GLPG Comparison
Open Charts ABCL vs GLPGBanner chart's image
AbCellera Biologics
Price$4.74
Change+$0.09 (+1.94%)
Volume$3.83M
Capitalization1.42B
Galapagos
Price$33.78
Change+$1.12 (+3.43%)
Volume$179.11K
Capitalization2.16B
ABCL vs GLPG Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. GLPG commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and GLPG is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ABCL: $4.74 vs. GLPG: $33.78)
Brand notoriety: ABCL and GLPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 81% vs. GLPG: 67%
Market capitalization -- ABCL: $1.42B vs. GLPG: $2.16B
ABCL [@Biotechnology] is valued at $1.42B. GLPG’s [@Biotechnology] market capitalization is $2.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileGLPG’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • GLPG’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and GLPG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while GLPG’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 4 bearish.
  • GLPG’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than GLPG.

Price Growth

ABCL (@Biotechnology) experienced а +5.10% price change this week, while GLPG (@Biotechnology) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

GLPG is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($2.16B) has a higher market cap than ABCL($1.42B). ABCL YTD gains are higher at: 61.775 vs. GLPG (22.836). ABCL has higher annual earnings (EBITDA): -197.92M vs. GLPG (-225.76M). GLPG has more cash in the bank: 3.09B vs. ABCL (553M). GLPG has less debt than ABCL: GLPG (8.44M) vs ABCL (142M). GLPG has higher revenues than ABCL: GLPG (276M) vs ABCL (32.9M).
ABCLGLPGABCL / GLPG
Capitalization1.42B2.16B66%
EBITDA-197.92M-225.76M88%
Gain YTD61.77522.836271%
P/E RatioN/A54.80-
Revenue32.9M276M12%
Total Cash553M3.09B18%
Total Debt142M8.44M1,682%
FUNDAMENTALS RATINGS
GLPG: Fundamental Ratings
GLPG
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLGLPG
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
56%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
54%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 9 days ago
60%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOGSX21.060.30
+1.45%
Live Oak Health Sciences
DESAX25.790.16
+0.62%
DWS ESG Core Equity A
JDEAX48.080.27
+0.56%
JPMorgan US Research Enhanced Equity A
MIOLX29.60N/A
N/A
Morgan Stanley Inst International Opp L
IGFRX24.63N/A
N/A
Invesco EQV International Equity R6

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.94%
CRSP - ABCL
58%
Loosely correlated
+2.24%
RXRX - ABCL
58%
Loosely correlated
+1.94%
ABSI - ABCL
55%
Loosely correlated
+3.02%
BEAM - ABCL
52%
Loosely correlated
-0.52%
NTLA - ABCL
50%
Loosely correlated
-1.81%
More

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+3.43%
BEAM - GLPG
40%
Loosely correlated
-0.52%
NTLA - GLPG
39%
Loosely correlated
-1.81%
RGNX - GLPG
38%
Loosely correlated
+3.10%
CRSP - GLPG
35%
Loosely correlated
+2.24%
ABCL - GLPG
35%
Loosely correlated
+1.94%
More